These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 34755858)

  • 1. Outcomes and Long-Term Effects of COVID-19 in Patients with Inflammatory Bowel Diseases - A Danish Prospective Population-Based Cohort Study with Individual-Level Data.
    Attauabi M; Dahlerup JF; Poulsen A; Hansen MR; Vester-Andersen MK; Eraslan S; Prahm AP; Pedersen N; Larsen L; Jess T; Neumann A; Haderslev KV; Molazahi A; Lødrup AB; Glerup H; Oppfeldt AM; Jensen MD; Theede K; Kiszka-Kanowitz M; Seidelin JB; Burisch J
    J Crohns Colitis; 2022 Jun; 16(5):757-767. PubMed ID: 34755858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of dementia in patients with inflammatory bowel disease: a Danish population-based study.
    Rønnow Sand J; Troelsen FS; Horváth-Puhó E; Henderson VW; Sørensen HT; Erichsen R
    Aliment Pharmacol Ther; 2022 Sep; 56(5):831-843. PubMed ID: 35781292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease Activity Patterns of Inflammatory Bowel Disease-A Danish Nationwide Cohort Study 1995-2018.
    Wewer MD; Langholz E; Munkholm P; Bendtsen F; Benedict Seidelin J; Burisch J
    J Crohns Colitis; 2023 Apr; 17(3):329-337. PubMed ID: 36124895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review and Meta-Analysis: Risk of Hospitalization in Patients with Ulcerative Colitis and Crohn's Disease in Population-Based Cohort Studies.
    Tsai L; Nguyen NH; Ma C; Prokop LJ; Sandborn WJ; Singh S
    Dig Dis Sci; 2022 Jun; 67(6):2451-2461. PubMed ID: 34379220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients.
    Juliao-Baños F; Kock J; Arrubla M; Calixto O; Camargo J; Cruz L; Hurtado J; Clavijo A; Donado J; Schwartz S; Abreu MT; Damas OM
    Medicine (Baltimore); 2021 Feb; 100(7):e24729. PubMed ID: 33607817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for the Occurrence and Severity of Vertebral Fractures in Inflammatory Bowel Disease Patients: A Nationwide Population-Based Cohort Study.
    Choi A; Jung SH; Kim S; Lee JS
    J Korean Med Sci; 2023 Jul; 38(28):e210. PubMed ID: 37463684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.
    Burisch J; Pedersen N; Čuković-Čavka S; Brinar M; Kaimakliotis I; Duricova D; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Andersen V; Krabbe S; Dahlerup JF; Salupere R; Nielsen KR; Olsen J; Manninen P; Collin P; Tsianos EV; Katsanos KH; Ladefoged K; Lakatos L; Björnsson E; Ragnarsson G; Bailey Y; Odes S; Schwartz D; Martinato M; Lupinacci G; Milla M; De Padova A; D'Incà R; Beltrami M; Kupcinskas L; Kiudelis G; Turcan S; Tighineanu O; Mihu I; Magro F; Barros LF; Goldis A; Lazar D; Belousova E; Nikulina I; Hernandez V; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    Gut; 2014 Apr; 63(4):588-97. PubMed ID: 23604131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
    Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
    World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Does Not Lead to an Increase in Corticosteroid Prescriptions in IBD Patients: A Nationwide Cohort Study.
    Nørgård BM; Zegers FD; Nielsen J; Knudsen T; Kjeldsen J
    Inflamm Bowel Dis; 2023 Sep; 29(9):1470-1476. PubMed ID: 37067508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesalazine in Inflammatory Bowel Disease and COVID-19: Hospitalization and Adverse In-Hospital Outcomes Based on Nationwide Data.
    Kjeldsen S; Nielsen J; Mertz Nørgård B; Kjeldsen J
    Inflamm Bowel Dis; 2022 Oct; 28(10):1513-1519. PubMed ID: 34849917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.
    Burisch J; Jess T; Egeberg A
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2704-2712.e3. PubMed ID: 30936024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden.
    Axelrad JE; Olén O; Sachs MC; Erichsen R; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sørensen HT; Ludvigsson JF
    Gut; 2021 Feb; 70(2):297-308. PubMed ID: 32474410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased risk of genital warts in inflammatory bowel disease: A Danish registry-based cohort study (1996-2018).
    Elmahdi R; Thomsen LT; Iversen AT; Allin KH; Kjaer SK; Jess T
    United European Gastroenterol J; 2022 Apr; 10(3):287-295. PubMed ID: 35297191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Influence of Antidepressants on the Disease Course Among Patients With Crohn's Disease and Ulcerative Colitis-A Danish Nationwide Register-Based Cohort Study.
    Kristensen MS; Kjærulff TM; Ersbøll AK; Green A; Hallas J; Thygesen LC
    Inflamm Bowel Dis; 2019 Apr; 25(5):886-893. PubMed ID: 30551218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic management and outcomes in inflammatory bowel diseases, 2010 to 2017 in cohorts from Denmark, Sweden and Norway.
    Zhao M; Lirhus S; Lördal M; Langholz E; Knudsen T; Voutilainen M; Høivik ML; Moum B; Anisdahl K; Saebø B; Haiko P; Malmgren C; Coskun M; Melberg HO; Burisch J
    Aliment Pharmacol Ther; 2022 Sep; 56(6):989-1006. PubMed ID: 35902223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study: Classification: Epidemiology.
    Schneeweiss MC; Kirchgesner J; Wyss R; Jin Y; York C; Merola JF; Mostaghimi A; Silverberg JI; Schneeweiss S; Glynn RJ
    Br J Dermatol; 2022 Nov; 187(5):692-703. PubMed ID: 35718888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal transplantation for treatment of inflammatory bowel disease.
    Imdad A; Nicholson MR; Tanner-Smith EE; Zackular JP; Gomez-Duarte OG; Beaulieu DB; Acra S
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012774. PubMed ID: 30480772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study.
    Bezzio C; Armuzzi A; Furfaro F; Ardizzone S; Milla M; Carparelli S; Orlando A; Caprioli FA; Castiglione F; Viganò C; Ribaldone DG; Zingone F; Monterubbianesi R; Imperatore N; Festa S; Daperno M; Scucchi L; Ferronato A; Pastorelli L; Balestrieri P; Ricci C; Cappello M; Felice C; Fiorino G; Saibeni S;
    Aliment Pharmacol Ther; 2021 Dec; 54(11-12):1432-1441. PubMed ID: 34694009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.